PR84228

WETTEREN, Belgium, June 2, 2020 /PRNewswire=KYODO JBN/ --

Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of

biopharmaceutical contract development and manufacturing services, is pleased

to announce that it has completed the acquisition of Granules OmniChem Private

Limited, purchasing the remaining 50 percent ownership interest from its joint

venture partner, Granules India Limited. The transaction, announced in August

2019, strengthens Aji Bio-Pharma's commitment to providing its clients

accessibility to a reliable and simplified CDMO supply chain across all sites

globally.

Logo - https://mma.prnewswire.com/media/751177/Aji_BioPharma_Logo.jpg

Now doing business as Ajinomoto Bio-Pharma Services India ("Aji Bio-Pharma

India"), the organization is fully integrated into Aji Bio-Pharma's global

operations. The Visakhapatnam, India site, which was designed, constructed and

is managed based on the Aji Bio-Pharma Belgian sites' GMP operating standards

and quality systems, has successfully supported a number of the world's leading

biopharmaceutical companies since its formation in 2011.

"The addition of Aji Bio-Pharma India is an integral extension of Aji

Bio-Pharma's dedication to its customers to be a leading global and

quality-driven CDMO with comprehensive service offerings," said David Enloe,

President and CEO, Ajinomoto Bio-Pharma Services. "We are excited to officially

welcome the Aji Bio-Pharma India team to our global family, and we look forward

to providing a further streamlined experience for our clients as they continue

to deepen their partnerships with us on essential programs in their product

pipeline."  

"We are very pleased to be a part of a worldwide network committed to

simplifying our clients' supply chain," said K.V.V. Raju, CEO, Ajinomoto

Bio-Pharma India Pvt. Ltd. He further added, "As a fully integrated member of

Aji Bio-Pharma, we are committed to advancing Aji Bio-Pharma's Vision Statement

of being a leading, trusted, innovative partner to our clients and our people."

About Ajinomoto Bio-Pharma Services

Ajinomoto Bio-Pharma Services is a fully integrated contract development and

manufacturing organization with sites in Belgium, United States, Japan, and

India, providing comprehensive development, cGMP manufacturing, and aseptic

fill finish services for small and large molecule APIs and intermediates.

Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and

capabilities for pre-clinical and pilot programs to commercial quantities,

including Corynex(R) protein expression technology, oligonucleotide synthesis,

antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis,

continuous flow manufacturing and more. Ajinomoto Bio-Pharma Services is

dedicated to providing a high level of quality and service to meet our client's

needs. Learn more: www.AjiBio-Pharma.com

SOURCE: Ajinomoto Bio-Pharma Services

CONTACT: info@us.ajibio-pharma.com